Form 485BXT VanEck ETF Trust
As filed with the Securities and Exchange Commission on June 5, 2026
1933 Act File No. 333-123257
1940 Act File No. 811-10325
United States Securities and Exchange Commission
Washington, D.C. 20549
FORM N-1A
Registration Statement Under the Securities Act of 1933 | ý | |||||||
Pre-Effective Amendment No. | o | |||||||
| Post Effective Amendment No. 2,944 | ý | |||||||
and/or | ||||||||
Registration Statement Under the Investment Company Act of 1940 | ý | |||||||
| Amendment No. 2,948 | ý | |||||||
VANECK ETF TRUST
(Exact Name of Registrant as Specified in its Charter)
666 Third Avenue, 9th Floor
New York, New York 10017
(Address of Principal Executive Offices)
(212) 293-2000
Registrant’s Telephone Number
Jonathan R. Simon, Esq.
Senior Vice President and General Counsel
Van Eck Associates Corporation
666 Third Avenue, 9th Floor
New York, New York 10017
(Name and Address of Agent for Service)
Copy to:
Allison M. Fumai, Esq.
Dechert LLP
1095 Avenue of the Americas
New York, New York 10036
Approximate Date of Proposed Public Offering: As soon as practicable after the effective date of this registration statement.
| IT IS PROPOSED THAT THIS FILING WILL BECOME EFFECTIVE (CHECK APPROPRIATE BOX) | |||||
| Immediately upon filing pursuant to paragraph (b) | |||||
| X | On June 22, 2026 pursuant to paragraph (b) | ||||
| 60 days after filing pursuant to paragraph (a)(1) | |||||
| On [date] pursuant to paragraph (a)(1) | |||||
| 75 days after filing pursuant to paragraph (a)(2) | |||||
| On [date] pursuant to paragraph (a)(2) of rule 485 | |||||
| IF APPROPRIATE, CHECK THE FOLLOWING BOX: | |||||
| X | This post-effective amendment designates a new effective date for a previously filed post-effective amendment. | ||||
EXPLANATORY NOTE
The purpose of this filing is to delay the effectiveness of the Registrant’s Post-Effective Amendment No. 2,935 to its Registration Statement until June 22, 2026. Parts A, B, and C of Registrant's Post-Effective Amendment No. 2,935 under the Securities Act of 1933 and No. 2,939 under the Investment Company Act of 1940, filed on March 25, 2026, are incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirements for effectiveness of this Registration Statement under Rule 485(b) under the Securities Act of 1933 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Juan in the Commonwealth of Puerto Rico on the 5th day of June, 2026.
| VANECK ETF TRUST | |||||||||||
| By: | /s/ Laura I. Martinez | ||||||||||
| Name: Laura I. Martinez | |||||||||||
| Title: Vice President and Assistant Secretary | |||||||||||
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following person in the capacities and on the date indicated.
/s/ David H. Chow* | Trustee | June 5, 2026 | ||||||||||||
| David H. Chow | ||||||||||||||
/s/ Laurie A. Hesslein* | Trustee | June 5, 2026 | ||||||||||||
| Laurie A. Hesslein | ||||||||||||||
/s/ R. Alastair Short* | Trustee | June 5, 2026 | ||||||||||||
| R. Alastair Short | ||||||||||||||
/s/ Peter J. Sidebottom* | Trustee | June 5, 2026 | ||||||||||||
| Peter J. Sidebottom | ||||||||||||||
/s/ Richard D. Stamberger* | Trustee | June 5, 2026 | ||||||||||||
| Richard D. Stamberger | ||||||||||||||
/s/ Jan F. van Eck* | President, Chief Executive Officer and Trustee | June 5, 2026 | ||||||||||||
| Jan F. van Eck | ||||||||||||||
/s/ John J. Crimmins* | Vice President, Chief Financial Officer and Principal Accounting Officer | June 5, 2026 | ||||||||||||
| John J. Crimmins | ||||||||||||||
| *By: | /s/ Laura I. Martinez | |||||||
| Laura I. Martinez | ||||||||
| Attorney-in-Fact | ||||||||
| June 5, 2026 | ||||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allergy/Immunology Leaders Unite to Strengthen the Specialty Workforce and Expand Access to High Quality Care
- Edison Innovations Renews License Agreement With Everlight Electronics Co., Ltd. For KSF Technology
- Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share